Bifogade filer
PDF
Kurs
-3,27%
Likviditet
4,16 MSEK
Kalender
| Tid* | ||
| 2025-02-28 | 08:00 | Bokslutskommuniké 2024 |
| 2024-10-31 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-29 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-18 | - | Årsstämma |
| 2024-05-16 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-29 | - | Bokslutskommuniké 2023 |
| 2023-11-13 | - | Extra Bolagsstämma 2023 |
| 2023-10-19 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-04 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2023-05-03 | - | Årsstämma |
| 2023-04-26 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-23 | - | Bokslutskommuniké 2022 |
| 2022-10-21 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-04 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2022-05-03 | - | Årsstämma |
| 2022-04-26 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-24 | - | Bokslutskommuniké 2021 |
| 2021-12-22 | - | Extra Bolagsstämma 2021 |
| 2021-10-20 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-16 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-04 | - | X-dag ordinarie utdelning ELOS B 1.50 SEK |
| 2021-05-03 | - | Årsstämma |
| 2021-04-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-24 | - | Bokslutskommuniké 2020 |
| 2020-10-20 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-16 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-05 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-22 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2020-04-21 | - | Årsstämma |
| 2020-02-18 | - | Bokslutskommuniké 2019 |
| 2019-10-24 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-18 | - | Kvartalsrapport 2019-Q2 |
| 2019-04-24 | - | X-dag ordinarie utdelning ELOS B 1.00 SEK |
| 2019-04-23 | - | Årsstämma |
| 2019-04-23 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-18 | - | Bokslutskommuniké 2018 |
| 2018-10-25 | - | Kvartalsrapport 2018-Q3 |
| 2018-07-19 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-25 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2018-04-24 | - | Årsstämma |
| 2018-04-24 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-19 | - | Bokslutskommuniké 2017 |
| 2017-10-24 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-25 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-27 | - | X-dag ordinarie utdelning ELOS B 1.30 SEK |
| 2017-04-26 | - | Årsstämma |
| 2017-04-26 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-24 | - | Bokslutskommuniké 2016 |
| 2016-10-26 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-24 | - | Kvartalsrapport 2016-Q2 |
| 2016-04-27 | - | X-dag ordinarie utdelning ELOS B 1.00 SEK |
| 2016-04-26 | - | Årsstämma |
| 2016-04-26 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-25 | - | Bokslutskommuniké 2015 |
| 2015-10-23 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-21 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-28 | - | X-dag ordinarie utdelning ELOS B 2.00 SEK |
| 2015-04-28 | - | X-dag bonusutdelning ELOS B 1 |
| 2015-04-27 | - | Årsstämma |
| 2015-04-27 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-19 | - | Bokslutskommuniké 2014 |
| 2014-10-24 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-22 | - | Kvartalsrapport 2014-Q2 |
| 2014-04-30 | - | X-dag ordinarie utdelning ELOS B 2.00 SEK |
| 2014-04-29 | - | Årsstämma |
| 2014-04-29 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-21 | - | Bokslutskommuniké 2013 |
| 2013-10-23 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-21 | - | Kvartalsrapport 2013-Q2 |
| 2013-04-26 | - | X-dag ordinarie utdelning ELOS B 1.00 SEK |
| 2013-04-25 | - | Årsstämma |
| 2013-04-25 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-22 | - | Bokslutskommuniké 2012 |
| 2012-10-26 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-22 | - | Kvartalsrapport 2012-Q2 |
| 2012-04-24 | - | X-dag ordinarie utdelning ELOS B 1.50 SEK |
| 2012-04-23 | - | Årsstämma |
| 2012-04-23 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-24 | - | Bokslutskommuniké 2011 |
| 2011-10-26 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-18 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-04 | - | X-dag ordinarie utdelning ELOS B 1.50 SEK |
| 2011-05-03 | - | Årsstämma |
| 2011-05-03 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-25 | - | Bokslutskommuniké 2010 |
| 2010-10-27 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-19 | - | Kvartalsrapport 2010-Q2 |
| 2010-04-29 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2010-04-28 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-25 | - | Bokslutskommuniké 2009 |
| 2009-10-23 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-20 | - | Kvartalsrapport 2009-Q2 |
| 2009-04-30 | - | X-dag ordinarie utdelning ELOS B 1.50 SEK |
| 2009-04-29 | - | Årsstämma |
| 2009-04-29 | - | Kvartalsrapport 2009-Q1 |
| 2008-04-29 | - | X-dag ordinarie utdelning ELOS B 1.50 SEK |
| 2007-04-26 | - | X-dag ordinarie utdelning ELOS B 0.50 SEK |
| 2006-04-28 | - | X-dag ordinarie utdelning ELOS B 1.25 SEK |
| 2005-05-20 | - | Split ELOS B 1:2 |
| 2005-05-04 | - | X-dag ordinarie utdelning ELOS B 2.50 SEK |
| 2004-04-30 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2003-05-07 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2002-04-26 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2001-04-27 | - | X-dag ordinarie utdelning ELOS B 2.25 SEK |
| 1995-06-15 | - | Split ELOS B 1:2 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
The board of directors of Elos Medtech has today resolved to apply for de-listing of the Company's shares from Nasdaq Stockholm as a result of TA Associates, through EM Intressenter AB ("EM Intressenter"), controlling more than 90 percent of the shares in Elos Medtech AB (publ) ("Elos Medtech" or the "Company"), today having initiated compulsory redemption of the remaining shares in the Company.
EM Intressenter has informed the board of directors of Elos Medtech that EM Intressenter initiates compulsory redemption of the remaining shares in Elos Medtech and requested that the shares in Elos Medtech are de-listed from Nasdaq Stockholm.
In light of the above, and in accordance with EM Intressenter's request, the board of directors of Elos Medtech has resolved to apply for de-listing of the Company's shares from Nasdaq Stockholm. The last day of trading in Elos Medtech's shares on Nasdaq Stockholm will be announced as soon as Elos Medtech has received confirmation thereof from Nasdaq Stockholm.
For further information, please contact:
Stefano Alfonsi, President and CEO, +44 772 04 98 342, email: stefano.alfonsi@elosmedtech.com
Magnus René, Chairman of the Board, +1 781 266 6957, email: magnus.rene@mareadvisory.com
About Elos Medtech
Elos Medtech is a leading development and production partner for medical devices and components, with a focus on dental and orthopedic implants and instruments. The Company operates from facilities in Sweden, Denmark, China, and the U.S. The customer base comprises international medical technology companies.
Elos Medtech has more than 650 employees and a turnover of approximately SEK 950 million. Elos Medtech has been listed on NASDAQ Stockholm AB since 1989. Elos Medtech's B share is categorized as a Health Care company on the Mid Cap list.
This is information that Elos Medtech AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above on November 21[st], 2023, at 20:30 (CET)